13THERAPEUTICS
13Therapeutics, Inc is a spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis. U.S. patents claiming the composition of the lead peptide and its use in all inflammatory conditions involving Toll-Like Receptor (TLR) signaling have been issued, and several additional patents have been issued. The company performs all in vitro testing in-house and subcontracts with OHSU and other academic instututions for animal model testing. The company is privately funded and has received NIH peer reviewed grants, including multiple Phase II and Phase II SBIR grants.
13THERAPEUTICS
Industry:
Health Care
Founded:
2008-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.13therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(503)525-4887
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Mobile Non Scaleable Content Microsoft Exchange Online Amazon Organization Schema Office 365 Mail Google Maps
Current Employees Featured
Founder
Investors List
NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) investment in Grant - 13Therapeutics
Official Site Inspections
http://www.13therapeutics.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "13Therapeutics"
Company
13Therapeutics, Inc is a spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis. The company performs all in vitro testing in-house and subcontracts with OHSU …See details»
13Therapeutics - Crunchbase Company Profile & Funding
13Therapeutics, Inc is a spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis. U.S. patents claiming the composition of …See details»
Management - 13therapeutics, Inc
Steven H. Hefeneider, Ph.D. is an Immunologist by training with a focus on immune regulation and Founder of 13therapeutics, Inc. Dr. Hefeneider serves as the company's CEO/President and is the co-inventor of the P13 peptide and …See details»
13Therapeutics Company Profile 2024: Valuation, Funding
13Therapeutics General Information Description. Operator of drug development and research company intended to develop novel peptide therapeutics. The company leverages technology …See details»
13therapeutics - LinkedIn
13therapeutics is a research and drug development company identifying and characterizing novel anti-inflammatory peptide therapeutics for unmet medical needs with high commercial potential.See details»
13therapeutics Overview | SignalHire Company Profile
Organization Website: 13therapeutics.com : 13therapeutics industries Biotech: Headquarters Location: 2611 SW 3RD AVE, ... DRUG DEVELOPMENT: Founded: 2008: 13therapeutics …See details»
13therapeutics, Inc. Company Profile | Management and
Founded in 2008, 13therapeutics is headquartered in Portland, Oregon. They are a research and drug development company that identify, characterize, and optimize anti-inflammatory peptide …See details»
13therapeutics, Inc. - Overview, News & Similar companies
Who is 13therapeutics, Inc. Founded in 2008, 13therapeutics is headquartered in Portland, Oregon. They are a research and drug development company that identify, characterize, and …See details»
13therapeutics - Craft
13therapeutics is a research and drug development company identifying and characterizing anti-inflammatory peptide therapeutics. It develops a platform for discovering peptides derived from …See details»
13therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Explore 13therapeutics with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Synthetic peptide ...See details»
13THERAPEUTICS, INC. - VentureRadar
13THERAPEUTICS, INC. VentureRadar profile. Find out more about 13THERAPEUTICS, INC., Peptide Therapeutics, Peptides, DNA, RNA and Peptide Therapies and .See details»
13therapeutics - Products, Competitors, Financials, Employees ...
13therapeutics is a biotechnology company focused on the research and development of novel anti-inflammatory peptide therapeutics. The company specializes in creating peptides that …See details»
13therapeutics - Company Profile & Staff Directory - ContactOut
13therapeutics is a research and drug development company identifying and characterizing novel anti-inflammatory peptide therapeutics for unmet medical needs with high commercial …See details»
Board of Directors - 13therapeutics, Inc
Denis R. Burger, Ph.D. is an immunologist by training with over 100 publications focused on regulation of the immune response.Dr. Burger was Chariman and co-founder of Epitope, Inc. …See details»
13Therapeutics - Contacts, Employees, Board Members, Advisors …
Organization. 13Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 2. …See details»
13Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 21, 2011: Grant - …See details»
13THERAPEUTICS, INC. - VentureRadar
Similar Companies: Protagonist Therapeutics USA Listed Protagonist Therapeutics is a clinical-stage biopharmaceutical company focused exclusively on peptide therapeutics to address …See details»
Steven Hefeneider - Founder @ 13Therapeutics - Crunchbase
Primary Organization . 13Therapeutics . Gender Male; Steven H. Hefeneider, Ph.D. is an Immunologist by training with a focus on immune regulation and Founder of 13therapeutics, …See details»
Annual Report on 13therapeutics's Revenue, Growth, SWOT …
Dec 2, 2024 13therapeutics's annual revenues are N/A (see exact revenue data) What industry is the company in? 13therapeutics is classified as operating in the Scientific Research & …See details»